| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 02/19/2004 | WO2004014871A1 Vanilloid receptor ligands and their use in treatments |
| 02/19/2004 | WO2004014868A2 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014867A2 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 02/19/2004 | WO2004014865A1 Phenylpyridazine derivatives as ligands for gaba receptors |
| 02/19/2004 | WO2004014864A1 1h-indazole-3-carboxamide compounds as cyclin dependent kinases (cdk) inhibitors |
| 02/19/2004 | WO2004014860A2 Fused heterocyclic compounds as peptidase inhibitors |
| 02/19/2004 | WO2004014852A2 Iminothiazolidinones as inhibitors of hcv replication |
| 02/19/2004 | WO2004014851A2 Tyrosine kinase inhibitors |
| 02/19/2004 | WO2004014389A1 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014381A2 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 02/19/2004 | WO2004014379A1 Isoquinoline derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014372A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 02/19/2004 | WO2004014371A1 Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors |
| 02/19/2004 | WO2004014369A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/19/2004 | WO2004014366A1 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014365A1 Phthalimide derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014316A2 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 02/19/2004 | WO2004014313A2 Combination pharmaceutical agents as inhibitors of hcv replication |
| 02/19/2004 | WO2004007481A3 Substituted amine derivatives and methods of use in the treatment of angiogenesis relates disorders |
| 02/19/2004 | WO2003060078A9 Heterocyclic modulators of nuclear receptors |
| 02/19/2004 | WO2003027234A9 Small organic molecule regulators of cell proliferation |
| 02/19/2004 | WO2002030356A3 Synthesis of epothilones and relates analogs |
| 02/19/2004 | US20040034232 Amide derivative |
| 02/19/2004 | US20040034229 3,4-Di-substituted maleimide compounds as CXC chemokine receptor antagonists |
| 02/19/2004 | US20040034222 Phenyloxyalkylamino substituted triazine compound, useful for applying to the parts of the plants, to plant seed or to the area under cultivation as plant growth regulator |
| 02/19/2004 | US20040034218 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 02/19/2004 | US20040034089 Such as (1-((2,3-dihydro-2-(4-propyl-1H-imidazol-2-yl)-1H-indol-1 -yl)carbonyl)propyl)-carbamate; for inactivation of cholecystokinins |
| 02/19/2004 | US20040034078 Such as 2-(2-butylamino-ethylsulfanylmethyl)-1H-benzimidazole-4-carboxylic acid amide for treatment of cancer, strokes, head trauma, and neurodengenerative diseases; solid phase synthesis |
| 02/19/2004 | US20040034066 Rosiglitazone hydrochloride is stable, water solubility, high melting point, bulk flow and good for bulk preparation and handling; salt formation |
| 02/19/2004 | US20040034064 2-(biarylalkyl)amino-3-(alkanoylamino)pyridine derivatives |
| 02/19/2004 | US20040034063 Antiallergens for treating and prevention of asthma |
| 02/19/2004 | US20040034061 An antagonist of corticotropin releasing factor receptor, treating depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastrointestinal disorders, drug dependence |
| 02/19/2004 | US20040034048 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 02/19/2004 | US20040034041 Novel anti-infectives |
| 02/19/2004 | US20040034034 Novel piperazine derivatives |
| 02/19/2004 | US20040034025 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
| 02/19/2004 | US20040034019 Piperazine and piperidine derivatives |
| 02/19/2004 | US20040034018 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders |
| 02/19/2004 | US20040034004 Bicyclic heterocycles for the treatment of diabetes and other diseases |
| 02/19/2004 | US20040033899 5[(pyrazol-4-yl)carbonyl]benzazolone as herbicide |
| 02/19/2004 | DE10236340A1 New heteroar(alkan)oyl-substituted phenyl-beta-alaninamide derivatives, useful as broad-spectrum antibacterial agents in human or veterinary medicine |
| 02/19/2004 | DE10235690A1 New N-benzyl-anthranilic acid (hetero)arylamide derivatives and analogs, are tyrosine kinase KDR and FLT inhibitors and angiogenesis inhibitors, useful e.g. for treating tumors, psoriasis or restenosis |
| 02/19/2004 | CA2497656A1 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | CA2495285A1 Phenylpyridazine derivatives as ligands for gaba receptors |
| 02/19/2004 | CA2495266A1 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 02/19/2004 | CA2495179A1 Compounds having an activity at metabotropic glutamate receptors |
| 02/19/2004 | CA2494298A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/19/2004 | CA2494259A1 Epothilone derivatives |
| 02/19/2004 | CA2493712A1 Aminothiazole derivatives as npy5 receptor inhibitors |
| 02/19/2004 | CA2492837A1 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 02/19/2004 | CA2492019A1 Isoquinoline derivatives as matrix metalloproteinase inhibitors |
| 02/18/2004 | EP1389617A1 Heterocyclic compound and antitumor agent containing the same as active ingredient |
| 02/18/2004 | EP1389616A1 Novel benzylpiperidine compound |
| 02/18/2004 | EP1389463A1 Medicine for inhibiting drug elimination pump |
| 02/18/2004 | EP1389206A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 02/18/2004 | EP1389202A1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 02/18/2004 | EP1389190A1 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring |
| 02/18/2004 | EP1389110A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 02/18/2004 | EP1196410B1 Respiratory syncytial virus replication inhibitors |
| 02/18/2004 | EP1178958B1 N-cyanomethyl amides as protease inhibitors |
| 02/18/2004 | EP1119568B1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 02/18/2004 | EP0944627B1 8-azabicyclo 3.2.1]octane-, 8-azabicyclo 3.2.1]oct-6-ene-, 9-azabicyclo 3.3.1]nonane-, 9-aza-3-oxabicyclo 3.3.1]nonane- and 9-aza-3-thiabicyclo 3.3.1]nonane derivatives, their preparation and their use as insecticides |
| 02/18/2004 | CN1476448A Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 02/18/2004 | CN1476447A Aminothiazoles and their use as adenosine receptor antagonists |
| 02/18/2004 | CN1476446A Benzodiazepine derivative |
| 02/18/2004 | CN1476436A Novel compounds for use as HIV protease inhibitors |
| 02/18/2004 | CN1476432A Indole and dihydroindole derivatives |
| 02/18/2004 | CN1476430A Delta 1-pyrrolines used as pesticides |
| 02/18/2004 | CN1476429A EP4 receptor selective agonists in treatment of osteoporosis |
| 02/18/2004 | CN1138765C Oxazolidinone antibacterial agents having thiocarbonyl functionality |
| 02/17/2004 | US6693200 2-(substituted-phenyl)amino-imidazoline derivatives |
| 02/17/2004 | US6693199 Deprotecting carbamate group and amidating in presence of such as hydroxybenzotriazole hydrate promoter |
| 02/17/2004 | US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia |
| 02/17/2004 | US6693121 As inhibitors of serine proteases of the coagulation cascade and compounds, used for anticoagulant therapy forprophylaxis of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases |
| 02/17/2004 | US6693106 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (AGE's) |
| 02/17/2004 | US6692905 Methine compound-containing silver halide photographic emulsion and photographic material using the same |
| 02/17/2004 | US6692776 Hydrating hair shafts to open flaps of the cuticles layer, applying amino acids or peptides to nourish hair, and compressing under heat by sandwiching between heated plates to cause penetration and close flap opening |
| 02/17/2004 | CA2302965C Processes and intermediates for preparing anti-cancer compounds |
| 02/17/2004 | CA2290918C Heteroaromatic bicyclic derivatives useful as anticancer agents |
| 02/12/2004 | WO2004013234A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
| 02/12/2004 | WO2004013153A2 Macrolide compounds endowed with antiinflammatory activity |
| 02/12/2004 | WO2004013135A1 2-phenylpyridin-4-yl derivatives as alk5 inhibitors |
| 02/12/2004 | WO2004013134A2 Compounds |
| 02/12/2004 | WO2004013133A1 Preparation of aztreonam |
| 02/12/2004 | WO2004013132A1 Furanthiazole derivatives as heparanase inhibitors |
| 02/12/2004 | WO2004013131A2 Pyridines and pyrimidines substituted by 4-trifluoromethylpyrazolyl |
| 02/12/2004 | WO2004013130A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 02/12/2004 | WO2004013120A1 Novel benzodioxoles |
| 02/12/2004 | WO2004013113A1 Substituted thiazines as material protecting agents |
| 02/12/2004 | WO2004013102A1 Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines |
| 02/12/2004 | WO2004013091A2 4-anilido substituted quinazolines and use thereof as inhibitors of epidermal growth factor receptor kinases |
| 02/12/2004 | WO2004012736A1 Biaryl compounds having anti-infective activity |
| 02/12/2004 | WO2004012735A2 New effector conjugates, process for their production and their pharmaceutical use |
| 02/12/2004 | WO2004012684A2 M3muscarinic acetylcholine receptor antagonists |
| 02/12/2004 | WO2004012648A2 Substituted diaryl heterocycles, method for the production and use thereof as medicaments |
| 02/12/2004 | WO2003049702A3 Vanilloid receptor ligands and their use in treatments |
| 02/12/2004 | WO2003037916A3 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 02/12/2004 | WO2003010159A8 Piperidine derivatives as nmda receptor antagonists |
| 02/12/2004 | WO2003008365A3 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 02/12/2004 | WO2002083863A3 Thiazole and other heterocyclic ligands and use thereof |